Psychedelics in Psychiatry: Questioning Objectivity and Exploring Trends
No, psychiatry is not an objective science. Unless you're measuring it in a double blind, you can't possibly get an objective measure of the impact of what that's doing: the person's expectations, their biology.
What happens when psychedelics meet psychiatry? In this thought-provoking episode of Diagnonsense, hosts Justin Pendergrass and Kurt Konek are joined by MY House CEO and psychologist Michelle Overstreet to tackle this intriguing question. They dive deep into the current trends in psychology and counterculture, focusing on the use of psychedelics in mental health treatment. The conversation is rich with history, covering the pharmacological revolution in psychiatry and questioning the financial motives behind psychiatric research. But it doesn’t stop there.
They also scrutinize the concept of objectivity in psychiatry, asking if it’s truly possible to be unbiased in a field so intertwined with human experience. Michelle brings her expertise to the table, discussing both the potential benefits and the risks of using psychedelics to treat mental illnesses. The episode also highlights the importance of double-blind studies and critical thinking in understanding the limitations of science.
If you’re curious about how counterculture influences psychiatry or skeptical about the one-size-fits-all approach to mental health treatment, this episode is for you. Tune in for a nuanced and eye-opening discussion that challenges conventional wisdom and encourages deeper reflection.